Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype
Clinical trial NCT06247670 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06247670
- Sponsor
- CAMP4 Therapeutics Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-05
- Primary completion
- 2027-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.